The Office of Portfolio Analysis (OPA) was established in 2011, and is part of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) within the Office of the NIH Director (OD).

OPA is an interdisciplinary team that impacts NIH-supported research by enabling NIH decision makers and research administrators to evaluate and prioritize current and emerging areas of research that will advance NIH’s mission.

• We teach and support portfolio analyses across NIH by offering training classes and one-on-one consultations.
• We innovate and expand NIH-wide efforts in portfolio analysis by developing new methodologies and data tools.
• We actively coordinate portfolio analysis activities across NIH and enhance collaboration among all portfolio analysis stakeholders by hosting poster sessions, workshops, and symposia

In response to analytical needs in connection with the SARS‑CoV‑2 pandemic, OPA has developed a comprehensive, expert-curated portfolio of COVID‑19 publications and preprints. Our iSearch COVID‑19 portfolio, which includes peer-reviewed articles from PubMed and preprints from medRxiv, SSRN, arXiv, bioRxiv, Research Square, and ChemRxiv, is updated daily with the latest available data. Access the tool here.